Showing results (241-250 of 492) with videos related to
Sort By:
Pageof 50
Canadian Liver Journal|September 22, 2022
A collaborative approach to hepatitis C testing in two First Nations communities of northwest OntarioDavid Smookler, Anne Beck, Brenda Head, et al.AIDS (London, England)|May 5, 2012
Virological responses during treatment for recent hepatitis C virus: potential benefit for ribavirin use in HCV/HIV co-infectionJason Grebely, Margaret Hellard, Tanya Applegate, et al.BMC Public Health|September 28, 2024
An evolutionary concept analysis: stigma among women living with hepatitis CChelsea Masterman, Andrew B Mendlowitz, Camelia Capraru, et al.Communications Medicine|May 12, 2023
Combined COVID-19 vaccination and hepatitis C virus screening intervention in marginalised populations in SpainJeffrey V Lazarus, Marcela Villota-Rivas, Pablo Ryan, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 31, 2024
Liver-restricted Type I IFN Signature Precedes Liver Damage in Chronic Hepatitis B Patients Stopping Antiviral TherapyConan Chua, Deeqa Mahamed, Shirin Nkongolo, et al.European Journal of Gastroenterology & Hepatology|June 22, 2011
Response to antiviral therapy in patients with genotype 3 chronic hepatitis C: fibrosis but not race encourages relapseDania Shoeb, Ian A Rowe, Dennis Freshwater, et al.Gastroenterology|June 20, 2012
Preserved T-cell function in children and young adults with immune-tolerant chronic hepatitis BPatrick T F Kennedy, Elena Sandalova, Juandy Jo, et al.The American Journal of Tropical Medicine and Hygiene|February 14, 2018
Rifaximin Reduces Markers of Inflammation and Bacterial 16S rRNA in Zambian Adults with Hepatosplenic Schistosomiasis: A Randomized Control TrialEdford Sinkala, Kanekwa Zyambo, Ellen Besa, et al.Journal of Hepatology|August 11, 2012
Hepatitis C infection, antiviral treatment and mental health: a European expert consensus statementMartin Schaefer, Lucile Capuron, Astrid Friebe, et al.Plos One|November 27, 2013
Plasma interferon-gamma-inducible protein-10 levels are associated with early, but not sustained virological response during treatment of acute or early chronic HCV infectionJordan J Feld, Jason Grebely, Gail V Matthews, et al.Pageof 50